URAKOV, A.L.,
MUSTAFIN, I.G.,
NABIULLINA, R.M.,
BASHIROVA, L.I.,
MOCHALOV, K.S.,
SAMORODOV, A.V.,
KHALIULLIN, F.A.,
LIPATOV, D.O.,
KORUNAS, V.I.,
KHALIMOV, A.R. (2020) of thromboelastography (TEG) as a screening method for products that affect the hemostatic system, the
safety assessment
to and inactivates NF-kappa B components. Until now, DHMEQ has been
used by many scientists in the world to suppress
popularity, including the
use of blood
components or blood cells with a haemostatic purpose. In this re gard